TEAM

Salesforce-A recommendation for a perilous market The title of this article comes from a quote by Ray Bradbury, a well known author, whose most famous work was “Fahrenheit 451.” I thought it particularly appropriate after the months of share price bloodletting.  I have not written about Salesforce (CRM) on the SA platform for about 4 years now. I…

To access this post, you must subscribe.

Read More

Many of the larger tech companies have now reported their earnings. If there are two consistent threads they are that overall, earnings have been a bit better than some have feared and that while some of the consumer focused tech vendors have encountered a variety of headwinds, for the most part that hasn’t been the…

To access this post, you must subscribe.

Read More

Summary Shares of High-Growth software companies have led the market down so far in 2022. The decline in valuations and absolute share prices has been at rates that rival anything in the recent past. This decline has occurred against a background of strong and growing demand in the Information Technology (IT) space. Ironically, software demand…

To access this post, you must subscribe.

Read More

Tuesday evening and Wednesday morning brought several announcements from software companies providing preliminary results for the quarter that ended on March 31st . The results for all of the companies listed above were significant beats. The theme is that the software industry is experiencing boom times engendered both by the wide scale acceptance of applications that…

To access this post, you must subscribe.

Read More

Earlier today, we made another change in our high-growth portfolio. We sold about 50% of our position in Atlassian-132 shares at $240.09.  This sale raised about $31,685.  Atlassian is a great company with a long runway of growth. But the shares have gained 25% in the last month. Part of that gain probably relates to…

To access this post, you must subscribe.

Read More

Investors seem to be suffering from a severe case of schizophrenia. Earlier in the week, work-from-home names heavily underperformed cyclical names, On Friday, investors seemed determined to erase that judgement. And indeed, one company whose management pointed out that it was concerned about the percentage growth of its Q4 backlog because of economic headwinds spawned…

To access this post, you must subscribe.

Read More

Summary Last week Atlassian announced results for its latest fiscal year that ended 6/30. The results unsurprisingly were another in a lengthy string of noticeable beats. Guidance was provided just for Q1 and it was essentially in line with prior estimates; full year guidance was not provided due to the lack of visibility. The company,…

To access this post, you must subscribe.

Read More

We are making the following changes in the high growth portfolio, effective today, July 23, 2020. We are selling an additional 125 shares of our Alteryx position at $171 which has yielded proceeds of $21,375 and we have sold 110 shares of our Atlassian position at $194.50 which has yielded proceeds of $21,395. The two…

To access this post, you must subscribe.

Read More

One subscriber wrote me that last week was a “hell of a week.” And so it was. I read a drumbeat of articles talking about bubbles and over-valuation. I have presented my thesis often enough. When I write articles and present investment ideas, I try to do so on the basis of logic and not…

To access this post, you must subscribe.

Read More

First, please accept my apologies regarding the lack of access many of you have had to the Ticker Target site the last few days. It was a priority to restore the service and we have it restored at this point. There are a couple of articles missing and they will be shortly restored as well.…

To access this post, you must subscribe.

Read More
{"cart_token":"","hash":"","cart_data":""}